CRP – a valuable source of information or just a laboratory test?
DOI:
https://doi.org/10.12775/JEHS.2023.45.01.026Keywords
autoimmune diseases, infections, cancers, C - reactive protein, inflammationAbstract
Background and Purpose: Laboratory tests are an inseparable element in modern medicine. They provide us with valuable clues for making a diagnosis or monitoring treatment. One of the most frequently ordered biochemical tests is the determination of the level of CRP in the blood. The aim of the study is to present the clinical usefulness of this study and to present knowledge about C-reactive protein.
Current state of knowledge: It is produced mainly by the liver, but the latest reports confirm local synthesis, among others, in arterial endothelial cells. The most common reason for the increase in the level of CRP is the appearance of infection, during which time its concentration may increase by up to 1000 times. Elderly patients have a weaker immune system response than younger patients, therefore the rise in CRP may be less pronounced. Other reasons are autoimmune diseases, cancer, or acute or chronic inflammation. As a result of cel damage, pro-inflammatory cytokines are secreted, which stimulate the production of CRP. Most scientific sources consider CRP ≥ 10 mg/L to be significant. Values of 3-10mg/L are considered a slight increase in CRP levels. Such CRP values were found in about 1/3 of the American population.
Conclusions: The CRP level should not be interpreted as an isolated medical parameter, but in conjunction with other tests and the patient's current state of health. Based on the amount of CRP in the blood and changes in its concentration over time, we can check the response to treatment and predict the course of some diseases.
References
Bansal T, Pandey A, D D, Asthana AK. C-Reactive Protein (CRP) and its Association with Periodontal Disease: A Brief Review. J Clin Diagn Res. 2014 Jul;8(7):ZE21-4. doi: 10.7860/JCDR/2014/8355.4646. Epub 2014 Jul 20. PMID: 25177663; PMCID: PMC4149169.
DuBrock HM, AbouEzzeddine OF, Redfield MM (2018) High-sensitivity C-reactive protein in heart failure with preserved ejection fraction. PLOS ONE 13(8): e0201836. https://doi.org/10.1371/journal.pone.0201836
Landry A, Docherty P, Ouellette S, Cartier LJ. Causes and outcomes of markedly elevated C-reactive protein levels. Can Fam Physician. 2017 Jun;63(6):e316-e323. PMID: 28615410; PMCID: PMC5471098.
Irving Kushner, Maria J. Antonelli. What Should We Regard as an “Elevated” C-Reactive Protein Level?. Ann Intern Med.2015;163:326. [Epub 18 August 2015]. doi:10.7326/L15-5126
Kushner I, Rzewnicki D, Samols D. What does minor elevation of C-reactive protein signify? Am J Med. 2006 Feb;119(2):166.e17-28. doi: 10.1016/j.amjmed.2005.06.057. PMID: 16443421.
Wium-Andersen MK, Ørsted DD, Nielsen SF, Nordestgaard BG. Elevated C-Reactive Protein Levels, Psychological Distress, and Depression in 73 131 Individuals. JAMA Psychiatry. 2013;70(2):176–184. doi:10.1001/2013.jamapsychiatry.102
Hart PC, Rajab IM, Alebraheem M, Potempa LA. C-Reactive Protein and Cancer-Diagnostic and Therapeutic Insights. Front Immunol. 2020 Nov 19;11:595835. doi: 10.3389/fimmu.2020.595835. PMID: 33324413; PMCID: PMC7727277.
Luan YY, Yao YM. The Clinical Significance and Potential Role of C-Reactive Protein in Chronic Inflammatory and Neurodegenerative Diseases. Front Immunol. 2018 Jun 7;9:1302. doi: 10.3389/fimmu.2018.01302. PMID: 29951057; PMCID: PMC6008573.
Soeters, P.B., Wolfe, R.R. and Shenkin, A. (2019), Hypoalbuminemia: Pathogenesis and Clinical Significance. Journal of Parenteral and Enteral Nutrition, 43: 181-193. https://doi.org/10.1002/jpen.1451
Zhu, M., Ma, Z., Zhang, X. et al. C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis. BMC Med 20, 301 (2022). https://doi.org/10.1186/s12916-022-02506-x
Liu, X., Mayes, M.D., Pedroza, C., Draeger, H.T., Gonzalez, E.B., Harper, B.E., Reveille, J.D. and Assassi, S. (2013), Does C-Reactive Protein Predict the Long-Term Progression of Interstitial Lung Disease and Survival in Patients With Early Systemic Sclerosis?. Arthritis Care & Research, 65: 1375-1380. https://doi.org/10.1002/acr.21968
Deng, Z., Zhao, P., Cao, C., Sun, S., Zhao, F., Lu, C., & Ma, H. (2014). C reactive protein as a prognostic marker in chronic obstructive pulmonary disease. Experimental and Therapeutic Medicine, 7, 443-446. https://doi.org/10.3892/etm.2013.1441
Fabio E. Ospina and others, Distinguishing infections vs flares in patients with systemic lupus erythematosus, Rheumatology, Volume 56, Issue suppl_1, April 2017, Pages i46–i54, https://doi.org/10.1093/rheumatology/kew340
Christophe Lelubre, Sophie Anselin, Karim Zouaoui Boudjeltia, Patrick Biston, Michaël Piagnerelli, "Interpretation of C-Reactive Protein Concentrations in Critically Ill Patients", BioMed Research International, vol. 2013, Article ID 124021, 11 pages, 2013. https://doi.org/10.1155/2013/124021
Sproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018 Apr 13;9:754. doi: 10.3389/fimmu.2018.00754. PMID: 29706967; PMCID: PMC5908901.
Wu, Yi, Potempa, Lawrence A., El Kebir, Driss and Filep, János G.. "C-reactive protein and inflammation: conformational changes affect function" Biological Chemistry, vol. 396, no. 11, 2015, pp. 1181-1197. https://doi.org/10.1515/hsz-2015-0149
Perez L. Acute phase protein response to viral infection and vaccination. Arch Biochem Biophys. 2019 Aug 15;671:196-202. doi: 10.1016/j.abb.2019.07.013. Epub 2019 Jul 16. PMID: 31323216; PMCID: PMC7094616.
Nicole Stancel and others, Interplay between CRP, Atherogenic LDL, and LOX-1 and Its Potential Role in the Pathogenesis of Atherosclerosis, Clinical Chemistry, Volume 62, Issue 2, 1 February 2016, Pages 320 327, https://doi.org/10.1373/clinchem.2015.243923
Adukauskienė D, Čiginskienė A, Adukauskaitė A, Pentiokinienė D, Šlapikas R, Čeponienė I. Clinical relevance of high sensitivity C-reactive protein in cardiology. Medicina (Kaunas). 2016;52(1):1-10. doi: 10.1016/j.medici.2015.12.001. Epub 2016 Jan 15. PMID: 26987494.
Ticinesi A, Lauretani F, Nouvenne A, Porro E, Fanelli G, Maggio M, Meschi T. C-reactive protein (CRP) measurement in geriatric patients hospitalized for acute infection. Eur J Intern Med. 2017 Jan;37:7-12. doi: 10.1016/j.ejim.2016.08.026. Epub 2016 Sep 1. PMID: 27594414.
Luan YY, Yin CH, Yao YM. Update Advances on C-Reactive Protein in COVID-19 and Other Viral Infections. Front Immunol. 2021 Aug 10;12:720363. doi: 10.3389/fimmu.2021.720363. PMID: 34447386; PMCID: PMC8382792.
Slaats J, Ten Oever J, van de Veerdonk FL, Netea MG. IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections. PLoS Pathog. 2016 Dec 15;12(12):e1005973. doi: 10.1371/journal.ppat.1005973. PMID: 27977798; PMCID: PMC5158075.
Tang JH, Gao DP, Zou PF. Comparison of serum PCT and CRP levels in patients infected by different pathogenic microorganisms: a systematic review and meta-analysis. Braz J Med Biol Res. 2018;51(7):e6783. doi: 10.1590/1414-431x20176783. Epub 2018 May 28. PMID: 29846409; PMCID: PMC5995041.
Hervé C, Laupèze B, Del Giudice G, Didierlaurent AM, Tavares Da Silva F. The how's and what's of vaccine reactogenicity. NPJ Vaccines. 2019 Sep 24;4:39. doi: 10.1038/s41541-019-0132-6. PMID: 31583123; PMCID: PMC6760227.
Asegaonkar SB, Asegaonkar BN, Takalkar UV, Advani S, Thorat AP. C-Reactive Protein and Breast Cancer: New Insights from Old Molecule. Int J Breast Cancer. 2015;2015:145647. doi: 10.1155/2015/145647. Epub 2015 Nov 26. PMID: 26693355; PMCID: PMC4674617.
Enocsson H, Karlsson J, Li HY, Wu Y, Kushner I, Wetterö J, Sjöwall C. The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus. J Clin Med. 2021 Dec 13;10(24):5837. doi: 10.3390/jcm10245837. PMID: 34945133; PMCID: PMC8708507.
Adukauskienė D, Čiginskienė A, Adukauskaitė A, Pentiokinienė D, Šlapikas R, Čeponienė I. Clinical relevance of high sensitivity C-reactive protein in cardiology. Medicina (Kaunas). 2016;52(1):1-10. doi: 10.1016/j.medici.2015.12.001. Epub 2016 Jan 15. PMID: 26987494.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Monika Leszcz, Marta Więckowska-Deroń, Karolina Nitka, Justyna Białek, Dominika Ćwik-Błotnicka, Joanna Borczyk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 421
Number of citations: 0